Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nuclear Consultants, Inc. was a pioneering American company in the field of nuclear medicine and radiopharmaceuticals. Founded in the early 1950s by Dr. Wilfred Konneker, it was one of the first commercial entities to process and distribute radioactive isotopes for medical diagnostic and therapeutic use. The company provided essential materials such as Iodine-131 and Gold-198 to hospitals, facilitating the growth of nuclear medicine departments across the United States. In 1966, the company was acquired by Mallinckrodt Chemical Works, serving as the foundation for Mallinckrodt's significant nuclear medicine business unit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nuclear Consultants.